MCIDT Affiliate Jason Pogue found that the antibiotic ceftolozane-tazobactam was associated with higher rates of clinical success in treating mutli-drug resistant Pseudomonas aeruginosa than the other common treatment ceftazidime-avibactam
Key Terms: Pseudomonas, Antibiotics, Drug Resistance
